zika

The Zika Threat

ASM Acts to Counter Zika Virus Outbreak.
Read

The Zika Diaries

Follow Dr. Vincent Racaniello’s lab as they work on Zika
at his Columbia University lab.
Read

Read a Book Chapter about Zika Virus

Werner Slenczka presents an overview of Zika Virus in the book Emerging Infections 10, just published by ASM Press.
Read
Become a member today!
JOIN ASM
Submit to an ASM Journal
SUBMIT
Register for the Beneficial Microbes Conference
REGISTER

Antimicrobial Chemotherapy
Division A is concerned with the discovery, mode of action, development and use of antimicrobial agents, and the mechanisms by which infective agents develop resistance to these compounds.

2013 Officers - all terms run from July 1, 2012 to June 30, 2013

Chair
Hanna M. Wexler
UCLA School of Medicine
Los Angeles, CA
hwexler@ucla.edu
310-268-3404

Chair-Elect
Jeffrey D. Alder
Bayer Healthcare Pharmaceuticals Inc.
Montville, NJ
jeff-lisa-alder@hotmail.com

Councilor
Linda A. Miller
GLAXOSMITHKLINE
Collegeville, PA
linda.a.miller@gsk.com
610-917-6280

Division A is part of Divisional Group II - Pathogenesis and Host Response Mechanisms

Divisional Group Representative
Victor DiRita
University of Michigan
Ann Arbor, MI
vdirita@umich.edu


Join DivANet

Website

 

TPL_asm2013_SEARCH

91500